The wide variety of anticoagulant and antiplatelet agents available for clinical use has made choosing the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention a complex task. While there is no single best regimen, from a risk-benefit ratio standpoint, particular regimens may be considered optimal for different patients. We review the mechanisms of action for the commonly prescribed antithrombotic medications, summarize pertinent data from randomized trials on their use in acute coronary syndromes, and provide an algorithm (incorporating data from these trials as well as risk assessment instruments) that will help guide the decision-making process. © 2009 Parikh and Keeley, publisher and licensee Dove Medical Press Ltd.
CITATION STYLE
Parikh, S. V., & Keeley, E. C. (2009). Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention. Vascular Health and Risk Management, 5, 677–691. https://doi.org/10.2147/vhrm.s4828
Mendeley helps you to discover research relevant for your work.